ChronoScale Corporation Common Stock (NASDAQ:CHRN) Sees Significant Decrease in Short Interest

ChronoScale Corporation Common Stock (NASDAQ:CHRN) saw a significant decrease in short interest in July. As of July 31st, there was short interest totaling 598,565 shares, a decrease of 49.4% from the July 15th total of 1,182,882 shares. Based on an average daily volume of 281,263 shares, the short-interest ratio is presently 2.1 days. Approximately 18.0% of the shares of the stock are sold short.

ChronoScale Corporation Common Stock Price Performance

Shares of CHRN traded up $0.30 during mid-day trading on Tuesday, reaching $22.49. 68,889 shares of the company’s stock were exchanged, compared to its average volume of 247,910. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The company has a 50-day simple moving average of $21.46 and a two-hundred day simple moving average of $15.37. ChronoScale Corporation Common Stock has a 52-week low of $3.05 and a 52-week high of $30.00. The company has a market cap of $80.06 million, a price-to-earnings ratio of -4.18 and a beta of 1.00.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its earnings results on Tuesday, June 30th. The company reported ($3.89) earnings per share (EPS) for the quarter. The company had revenue of $18.09 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. On average, sell-side analysts predict that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

A number of large investors have recently made changes to their positions in CHRN. TrinityBridge Ltd acquired a new position in ChronoScale Corporation Common Stock in the 2nd quarter valued at about $182,441,000. Citadel Advisors LLC acquired a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $198,000. Geode Capital Management LLC boosted its stake in shares of ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares during the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of ChronoScale Corporation Common Stock during the second quarter worth about $1,085,000. Finally, Shay Capital LLC purchased a new stake in shares of ChronoScale Corporation Common Stock during the third quarter worth about $67,000. Institutional investors and hedge funds own 6.42% of the company’s stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.